{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T17:39:13Z","timestamp":1771522753282,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013061","name":"Jilin Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["YDZJ202301ZYTS131"],"award-info":[{"award-number":["YDZJ202301ZYTS131"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013061","name":"Jilin Scientific and Technological Development Program","doi-asserted-by":"publisher","award":["20240304060SF"],"award-info":[{"award-number":["20240304060SF"]}],"id":[{"id":"10.13039\/501100013061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019594","name":"Yanbian University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.intimp.2025.115995","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:55:37Z","timestamp":1765299337000},"page":"115995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TMEM205 promotes cisplatin resistance in triple-negative breast cancer and induces TAM\/M2 polarization"],"prefix":"10.1016","volume":"169","author":[{"given":"Xia","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongshu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiafeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiefeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115995_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2025.115995_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2025.115995_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","article-title":"Advances in immunotherapy for triple-negative breast cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2025.115995_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj4009","article-title":"SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1","volume":"10","author":"Deng","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2025.115995_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114914","article-title":"PFKFB3 confers cisplatin resistance in gastric cancer by inhibiting ferroptosis through SLC7A11\/xCT dephosphorylation","volume":"159","author":"He","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115995_bb0030","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1186\/s12885-019-6278-9","article-title":"Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance","volume":"19","author":"Hill","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.intimp.2025.115995_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01345","article-title":"TMEM proteins in Cancer: a review","volume":"9","author":"Schmit","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115995_bb0040","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jcp.22287","article-title":"Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance","volume":"225","author":"Shen","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2025.115995_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11095-011-0562-y","article-title":"RAB8 enhances TMEM205-mediated cisplatin resistance","volume":"29","author":"Shen","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.intimp.2025.115995_bb0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ygyno.2021.10.076","article-title":"Aberrant expression of TMEM205 signaling promotes platinum resistance in ovarian cancer: an implication for the antitumor potential of DAP compound","volume":"164","author":"Calo","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.intimp.2025.115995_bb0055","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s10120-024-01517-2","article-title":"TMEM205 induces TAM\/M2 polarization to promote cisplatin resistance in gastric cancer","volume":"27","author":"Fu","year":"2024","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.intimp.2025.115995_bb0060","article-title":"Shaping polarization of tumor-associated macrophages in Cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115995_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111940","article-title":"Glycolytic reprogramming in macrophage polarization: new horizons in the treatment of tumor diseases","volume":"134","author":"Wang","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2025.115995_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115995_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111407","article-title":"Pancreatic cancer stem cell-derived exosomal miR-210 mediates macrophage M2 polarization and promotes gemcitabine resistance by targeting FGFRL1","volume":"127","author":"Guo","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115995_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.575776","article-title":"TMEM205 is an independent prognostic factor and is associated with immune cell infiltrates in hepatocellular carcinoma","volume":"11","author":"Rao","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.intimp.2025.115995_bb0085","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.7150\/ijbs.104850","article-title":"The SGK3\/GSK3\u03b2\/\u03b2-catenin signaling promotes breast cancer stemness and confers resistance to alpelisib therapy","volume":"21","author":"Kang","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.115995_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117090","article-title":"Design, synthesis and biological evaluation of biaryl amide derivatives as modulators of multi-drug resistance","volume":"282","author":"Peng","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2025.115995_bb0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/carcin\/bgad086","article-title":"Actinomycin D synergizes with doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis","volume":"45","author":"Yang","year":"2024","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.intimp.2025.115995_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40364-025-00779-x","article-title":"Decoding tumor angiogenesis: pathways, mechanisms, and future directions in anti-cancer strategies","volume":"13","author":"Liu","year":"2025","journal-title":"Biomark. Res."},{"key":"10.1016\/j.intimp.2025.115995_bb0105","article-title":"Conventional techniques and emerging nanotechnologies for early detection of cancer metastasis via epithelial-mesenchymal transition monitoring","volume":"12","author":"Zhang","year":"2025","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.intimp.2025.115995_bb0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12943-025-02306-w","article-title":"Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation","volume":"24","author":"Tufail","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2025.115995_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116848","article-title":"Therapeutic targets in the Wnt signaling pathway: treating cancer with specificity","volume":"236","author":"Zhang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115995_bb0120","article-title":"Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy","volume":"16","author":"He","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115995_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1573917","article-title":"Targeting tumor-associated macrophages in colon cancer: mechanisms and therapeutic strategies","volume":"16","author":"Xiang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115995_bb0130","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41419-018-0818-0","article-title":"Crosstalk between hepatic tumor cells and macrophages via Wnt\/\u03b2-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.115995_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274886","article-title":"Tumor growth monitoring in breast cancer xenografts: a good technique for a strong ethic","volume":"17","author":"Rodallec","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2025.115995_bb0140","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10911-024-09555-3","article-title":"Fast ultrasound scanning is a rapid, sensitive, precise and cost-effective method to monitor tumor grafts in mice","volume":"29","author":"Moli\u00e8re","year":"2024","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.intimp.2025.115995_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108253","article-title":"Triple negative breast cancer (TNBC): non-genetic tumor heterogeneity and immune microenvironment: emerging treatment options","volume":"237","author":"So","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2025.115995_bb0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tbcr-23-17","article-title":"Narrative review on the role of immunotherapy in early triple negative breast cancer: unveiling opportunities and overcoming challenges","volume":"4","author":"Qian","year":"2023","journal-title":"Transl. Breast Cancer Res."},{"key":"10.1016\/j.intimp.2025.115995_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109789","article-title":"Corrigendum to Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression Biomed. Pharmacother","volume":"122","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.115995_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216842","article-title":"SOD1-high fibroblasts derived exosomal miR-3960 promotes cisplatin resistance in triple-negative breast cancer by suppressing BRSK2-mediated phosphorylation of PIMREG","volume":"590","author":"Li","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.intimp.2025.115995_bb0165","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/01635581.2019.1650192","article-title":"Silencing of TMEM158 inhibits tumorigenesis and multidrug resistance in colorectal Cancer","volume":"72","author":"Liu","year":"2020","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.intimp.2025.115995_bb0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10528-021-10094-3","article-title":"TMEM45A affects proliferation, apoptosis, epithelial-mesenchymal transition, migration, invasion and cisplatin resistance of HPV-positive cervical Cancer cell lines","volume":"60","author":"Liu","year":"2022","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.intimp.2025.115995_bb0175","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s12276-024-01206-1","article-title":"Transmembrane proteins with unknown function (TMEMs) as ion channels: electrophysiological properties, structure, and pathophysiological roles","volume":"56","author":"Kang","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115995_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1244740","article-title":"The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer","volume":"13","author":"Herrera-Quiterio","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.115995_bb0185","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semcancer.2019.08.018","article-title":"Transmembrane (TMEM) protein family members: poorly characterized even if essential for the metastatic process","volume":"60","author":"Marx","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2025.115995_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100899","article-title":"Plasticity of cancer cell invasion: patterns and mechanisms","volume":"14","author":"Wu","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.intimp.2025.115995_bb0195","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1111\/jcmm.17572","article-title":"TMEM184B promotes proliferation, migration and invasion, and inhibits apoptosis in hypopharyngeal squamous cell carcinoma","volume":"26","author":"Lin","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115995_bb0200","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/jcp.29181","article-title":"TMEM158 promotes pancreatic cancer aggressiveness by activation of TGF\u03b21 and PI3K\/AKT signaling pathway","volume":"235","author":"Fu","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2025.115995_bb0205","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12967-021-02781-x","article-title":"TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB\/PI3K\/AKT signaling pathway","volume":"19","author":"Sun","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115995_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04369-1","article-title":"TMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.115995_bb0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cac2.12138","article-title":"EMT-associated microRNAs and their roles in cancer stemness and drug resistance","volume":"41","author":"Pan","year":"2021","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.intimp.2025.115995_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111680","article-title":"FOXC1 promotes EMT and colorectal cancer progression by attracting M2 macrophages via the TGF-\u03b2\/Smad2\/3\/snail pathway","volume":"130","author":"Zhang","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2025.115995_bb0225","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s41417-021-00414-5","article-title":"TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas","volume":"29","author":"Li","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.intimp.2025.115995_bb0230","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.7150\/jca.65822","article-title":"TMEM158 regulates the canonical and non-canonical pathways of TGF-\u03b2 to mediate EMT in triple-negative breast Cancer","volume":"13","author":"Tong","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.intimp.2025.115995_bb0235","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.biopha.2018.05.016","article-title":"Knockdown of TMEM45B inhibits cell proliferation and invasion in gastric cancer","volume":"104","author":"Shen","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.115995_bb0240","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1002\/jcb.28057","article-title":"TMEM106A inhibits cell proliferation, migration, and induces apoptosis of lung cancer cells","volume":"120","author":"Liu","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2025.115995_bb0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2025.115995_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111196","article-title":"H3K27ac-induced RHOXF2 activates Wnt2\/\u03b2-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer","volume":"120","author":"Guo","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2025.115995_bb0255","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/med.21787","article-title":"Direct targeting of \u03b2-catenin in the Wnt signaling pathway: current progress and perspectives","volume":"41","author":"Wang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.intimp.2025.115995_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112193","article-title":"Transmembrane protein 88 exerts a tumor-inhibitory role in thyroid cancer through restriction of Wnt\/\u03b2-catenin signaling","volume":"395","author":"Geng","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2025.115995_bb0265","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/10799893.2020.1813761","article-title":"TMEM48 promotes cell proliferation and invasion in cervical cancer via activation of the Wnt\/\u03b2-catenin pathway","volume":"41","author":"Jiang","year":"2021","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.intimp.2025.115995_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04211-8","article-title":"Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer","volume":"12","author":"Zhu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.115995_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116154","article-title":"Wnt signaling: modulating tumor-associated macrophages and related immunotherapeutic insights","volume":"223","author":"Yuan","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115995_bb0280","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1878-0261.12606","article-title":"Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt\/\u03b2-catenin signaling","volume":"14","author":"Tian","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.intimp.2025.115995_bb0285","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.intimp.2025.115995_bb0290","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","article-title":"Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer","volume":"23","author":"Kundu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2025.115995_bb0295","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7150\/thno.51777","article-title":"Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2025.115995_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113944","article-title":"SPP1-mediated M2 macrophage polarization shapes the tumor microenvironment and enhances prognosis and immunotherapy guidance in nasopharyngeal carcinoma","volume":"147","author":"Huang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.115995_bb0305","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.3748\/wjg.v27.i36.6079","article-title":"Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells","volume":"27","author":"Cui","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.115995_bb0310","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004029","article-title":"CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype","volume":"10","author":"Li","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2025.115995_bb0315","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1111\/jcmm.17998","article-title":"Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages","volume":"27","author":"Wu","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2025.115995_bb0320","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925019836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925019836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:58:57Z","timestamp":1771520337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925019836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":64,"alternative-id":["S1567576925019836"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115995","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TMEM205 promotes cisplatin resistance in triple-negative breast cancer and induces TAM\/M2 polarization","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115995"}}